Author

Vivian Wang

Brigham and Women's HospitalPrimary ORCID profile (0009-0005-7774-1573 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Vivian WangiD1 paper · University of Toronto

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Aaron David SchimmeriD· 1 shared Abdula MaheriD· 1 shared Ahmed A. Sadek· 1 shared Alex C.H. LiuiD· 1 shared Alex K. ShalekiD· 1 shared Andrea ArrudaiD· 1 shared Assunta De RienzoiD· 1 shared Benjamin J. WadowskiiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aaron David SchimmerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD59 organizes the plasma membrane to sustain oncogenic Ras-MAPK signaling and is a targetable vulnerability in acute myeloid leukemia

Abdula Maher, Dhanoop Manikoth Ayyathan, Séverine Cathelin, Paige Roehrig, Stephanie Z. Liu, Yitong Yang, Alex C.H. Liu, Mohsen Hosseini, Elise Quadri, Tiffany Villeneuve, Simi Kaur, Vivian Wang, Erwin M. Schoof, Andrea Arruda, Mark David Minden, , Steven M. Chan

This study identifies CD59 as a critical regulator of Ras-MAPK signaling in AML, showing its depletion impairs leukemic growth and identifies rILYd4 as a potential therapeutic target.

bioRxiv · Aug 12, 2026 · PreprintCancer Biology

Comprehensive multi-site profiling of the malignant pleural mesothelioma micro-environment identifies candidate molecular determinants of histopathologic type

David T. Severson, Samuel T. Freyaldenhoven, Benjamin J. Wadowski, Yin Pun Hung, Travis K. Hughes, Beow Yong Yeap, William G. Richards, Sanna Laaksonen, Lucian R. Chirieac, Matthew Brian Couger, Roderick V. Jensen, Ahmed A. Sadek, Ilkka Ilonen, Kimberly Vermilya, Simona Innocenti, , Raphael Bueno

This study uses single-cell RNA-sequencing and other omics data to analyze the molecular features of pleural mesothelioma subtypes and identify potential drivers of tumor cell states.

Journal of Thoracic Oncology · Nov 28, 2025Peer-reviewedCancer Biology